The Fab fragment of a novel anti-GPVI monoclonal antibody, OM4, reduces in vivo thrombosis without bleeding risk in rats - Li, H; Lockyer, S; Concepcion, A (Arterioscler Thromb Vasc Biol, 2007)
et al.